[Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)]. Academic Article uri icon

Overview

abstract

  • A double-blind study was conducted in four hospitals to test the effect of (+)-cyanidanol-3 (Catergen) on the course of acute viral hepatitis. Activities of a number of enzymes, bilirubin levels and gamma-globulin concentrations, as well as elimination of HBs antigen in blood were measured serially in 73 patients with viral hepatitis, 37 being treated with the drug, 36 patients receiving a placebo. In addition, liver biopsies before and after treatment were compared (19 patients treated, 23 patients on placebo). There was no significant difference between the treatment and placebo groups with regards to morphological and biochemical changes.

publication date

  • March 7, 1980

Research

keywords

  • Benzopyrans
  • Catechin
  • Hepatitis, Viral, Human

Identity

Scopus Document Identifier

  • 0018855172

Digital Object Identifier (DOI)

  • 10.1055/s-2008-1070660

PubMed ID

  • 6153953

Additional Document Info

volume

  • 105

issue

  • 10